Clincosm LogoSign in Get a demo

nonalcoholic fatty liver disease

Showing 1 - 25 of 85
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hyperoxaluria, Nonalcoholic Fatty Liver Disease, Kidney Stone Trial in United States (BMN 255, Placebo)

Recruiting
  • Hyperoxaluria
  • +2 more
  • BMN 255
  • Placebo
  • Birmingham, Alabama
  • +6 more
Nov 16, 2023

Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -

Completed
  • Nonalcoholic Fatty Liver Disease
  • Anti-human CCL24 monoclonal antibody (CM-101) - Part One
  • +3 more
  • Jerusalem, Israel
    Hadassah University Hospital - Ein Kerem
Sep 13, 2023

Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial (Efinopegdutide, Semaglutide, Placebo)

Not yet recruiting
  • Non-alcoholic Fatty Liver Disease
  • +4 more
  • (no location specified)
May 17, 2023

Nonalcoholic Fatty Liver Disease, Type 2 Diabetes Trial in Riyadh

Recruiting
  • Nonalcoholic Fatty Liver Disease
  • Type 2 Diabetes Mellitus
    • Riyadh, Select A State Or Province, Saudi Arabia
      King Fahad Medical City
    Jan 25, 2023

    Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial in San Antonio (AZD7503 Intervention)

    Active, not recruiting
    • Non-alcoholic Fatty Liver Disease
    • +5 more
    • AZD7503 Intervention
    • San Antonio, Texas
      Research Site
    Jan 13, 2023

    Observational Study About Patients Diagnosed With NAFLD

    Recruiting
    • Nonalcoholic Fatty Liver Disease
      • Changsha, Hunan, China
        Department of Infectious Disease, Xiangya Hospital, Central Sout
      Nov 25, 2022

      Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis Trial in Worldwide (Efinopegdutide 20 mg/mL, Semaglutide 1.34

      Completed
      • Nonalcoholic Fatty Liver Disease
      • Nonalcoholic Steatohepatitis
      • Efinopegdutide 20 mg/mL
      • Semaglutide 1.34 mg/mL
      • Montclair, California
      • +68 more
      Nov 1, 2022

      Obesity, Nonalcoholic Fatty Liver Disease, Cardiovascular Disease Trial in Jacksonville (N-acetyl cysteine 600 mg once/day,

      Completed
      • Obesity
      • +2 more
      • N-acetyl cysteine 600 mg once/day
      • +2 more
      • Jacksonville, Florida
        Nemours Children's Clinic/Alfred I duPont Hospital
      Oct 13, 2022

      Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis Trial in United States (d-alpha-tocopherol, Placebo)

      Recruiting
      • Nonalcoholic Fatty Liver Disease
      • Nonalcoholic Steatohepatitis
      • Vitamin E
      • Placebo
      • La Jolla, California
      • +8 more
      Oct 5, 2022

      Weight Gain After Smoking Cessation and NAFLD

      Completed
      • Nonalcoholic Fatty Liver Disease
      • Type 2 Diabetes
        • Ningbo, Zhejiang, China
          Ningbo first hospital
        Sep 20, 2022

        Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver

        Not yet recruiting
        • Nonalcoholic Fatty Liver Disease
        • Endoscopic Sleeve Gastroplasty
        • Morgantown, West Virginia
          West Virginia University
        Aug 16, 2022

        Nonalcoholic Fatty Liver Disease, Type 2 Diabetes Trial in Damanhur (Dapagliflozin 10mg Tab, Placebo)

        Recruiting
        • Nonalcoholic Fatty Liver Disease
        • Type 2 Diabetes
        • Dapagliflozin 10mg Tab
        • Placebo
        • DamanhÅ«r, Elbehairah, Egypt
          Rehab Hussein Werida
        Aug 11, 2022

        Nonalcoholic Fatty Liver Disease Trial in Dongguan (Silibinin extract, mixed power of pueraria, schisandra and salvia

        Recruiting
        • Nonalcoholic Fatty Liver Disease
        • Silibinin extract, mixed power of pueraria, schisandra and salvia miltiorrhiza
        • +2 more
        • Dongguan, Guangdong, China
          Department of Nutrition, School of Public Health, Guangdong Medi
        Aug 9, 2022

        Nonalcoholic Fatty Liver Disease Trial (Gastric Bypass Stent System in Treatment of Patients with Nonalcoholic Fatty Liver

        Not yet recruiting
        • Nonalcoholic Fatty Liver Disease
        • Gastric Bypass Stent System in Treatment of Patients with Nonalcoholic Fatty Liver Disease
        • (no location specified)
        Aug 8, 2022

        Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)

        Enrolling by invitation
        • Nonalcoholic Fatty Liver Disease
          • Nashville, Tennessee
            Vanderbilt University Medical Center
          Jul 5, 2022

          Nonalcoholic Fatty Liver Disease Trial in Ann Arbor (diet and lifestyle program)

          Active, not recruiting
          • Nonalcoholic Fatty Liver Disease
          • diet and lifestyle program
          • Ann Arbor, Michigan
            University of Michigan
          May 18, 2022

          NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients

          Not yet recruiting
          • Nonalcoholic Fatty Liver Disease
          • +3 more
            • (no location specified)
            Apr 18, 2022

            Gut Microbiota in Chronic Noncommunicable Diseases

            Completed
            • Arterial Hypertension
            • +7 more
              • Moscow, Russian Federation
              • +1 more
              Apr 18, 2022

              Nonalcoholic Fatty Liver Disease Trial in Guangzhou (Time restricted feeding, Continuous Energy Restriction)

              Completed
              • Nonalcoholic Fatty Liver Disease
              • Time restricted feeding
              • Continuous Energy Restriction
              • Guangzhou, Guangdong, China
                Nanfang Hospital of Southern Medical University
              Apr 5, 2022

              Nonalcoholic Fatty Liver Disease Trial in United States (BMS-963272, Placebo matching BMS-963272)

              Terminated
              • Nonalcoholic Fatty Liver Disease
              • Cullman, Alabama
              • +18 more
              Mar 16, 2022

              Nonalcoholic Fatty Liver Disease Trial in Atlanta (Guided Grocery Shopping (GGS), Diet Provision Group)

              Completed
              • Nonalcoholic Fatty Liver Disease
              • Guided Grocery Shopping (GGS)
              • Diet Provision Group
              • Atlanta, Georgia
              • +1 more
              Mar 23, 2022

              Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis Trial in Hungary, Poland, Spain (Placebo, FM101 150 mg BID, FM101

              Recruiting
              • Nonalcoholic Fatty Liver Disease
              • Nonalcoholic Steatohepatitis
              • Placebo
              • +2 more
              • Budapest, Hungary
              • +11 more
              Mar 4, 2022

              Fatty Liver, Nonalcoholic, NAFLD, Nonalcoholic Fatty Liver Disease Trial in United States (HTD1801, Placebo)

              Completed
              Has Results
              • Fatty Liver, Nonalcoholic
              • +5 more
              • Chandler, Arizona
              • +16 more
              Nov 30, 2021

              Obesity, Weight Loss, Body Weight Trial in Saint Louis (Embospheres Microspheres)

              Not yet recruiting
              • Obesity
              • +5 more
              • Embospheres Microspheres
              • Saint Louis, Missouri
                Saint Louis University
              Nov 15, 2021

              Obesity, Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver Disease Trial in Cincinnati (Comprehensive Lifestyle

              Completed
              • Obesity
              • +2 more
              • Comprehensive Lifestyle Intervention
              • Cincinnati, Ohio
                Cincinnati Children's Hospital Medical Center
              Nov 1, 2021